140 related articles for article (PubMed ID: 29956365)
1. Properties of composite time to first event versus joint marginal analyses of multiple outcomes.
Bebu I; Lachin JM
Stat Med; 2018 Nov; 37(27):3918-3930. PubMed ID: 29956365
[TBL] [Abstract][Full Text] [Related]
2. Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes.
Lachin JM; Bebu I
Clin Trials; 2015 Dec; 12(6):627-33. PubMed ID: 26336199
[TBL] [Abstract][Full Text] [Related]
3. A win ratio approach to the re-analysis of Multiple Risk Factor Intervention Trial.
Kotalik A; Eaton A; Lian Q; Serrano C; Connett J; Neaton JD
Clin Trials; 2019 Dec; 16(6):626-634. PubMed ID: 31389723
[TBL] [Abstract][Full Text] [Related]
4. Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales.
Lachin JM
PLoS One; 2014; 9(10):e108784. PubMed ID: 25329662
[TBL] [Abstract][Full Text] [Related]
5. Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.
Bebu I; Lachin JM
Biostatistics; 2016 Jan; 17(1):178-87. PubMed ID: 26353896
[TBL] [Abstract][Full Text] [Related]
6. Weighted composite time to event endpoints with recurrent events: comparison of three analytical approaches.
Ozga AK; Rauch G
BMC Med Res Methodol; 2022 Feb; 22(1):38. PubMed ID: 35123397
[TBL] [Abstract][Full Text] [Related]
7. Event-specific win ratios and testing with terminal and non-terminal events.
Yang S; Troendle J
Clin Trials; 2021 Apr; 18(2):180-187. PubMed ID: 33231108
[TBL] [Abstract][Full Text] [Related]
8. Opportunities and challenges of combined effect measures based on prioritized outcomes.
Rauch G; Jahn-Eimermacher A; Brannath W; Kieser M
Stat Med; 2014 Mar; 33(7):1104-20. PubMed ID: 24122841
[TBL] [Abstract][Full Text] [Related]
9. A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components.
Dong G; Li D; Ballerstedt S; Vandemeulebroecke M
Pharm Stat; 2016 Sep; 15(5):430-7. PubMed ID: 27485522
[TBL] [Abstract][Full Text] [Related]
10. Win ratio approach for analyzing composite time-to-event endpoint with opposite treatment effects in its components.
Liao R; Chakladar S; Gamalo M
Pharm Stat; 2022 Nov; 21(6):1342-1356. PubMed ID: 35766113
[TBL] [Abstract][Full Text] [Related]
11. Weighted win loss approach for analyzing prioritized outcomes.
Luo X; Qiu J; Bai S; Tian H
Stat Med; 2017 Jul; 36(15):2452-2465. PubMed ID: 28343373
[TBL] [Abstract][Full Text] [Related]
12. Graphing the Win Ratio and its components over time.
Finkelstein DM; Schoenfeld DA
Stat Med; 2019 Jan; 38(1):53-61. PubMed ID: 30206956
[TBL] [Abstract][Full Text] [Related]
13. The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.
Abdalla S; Montez-Rath ME; Parfrey PS; Chertow GM
Contemp Clin Trials; 2016 May; 48():119-24. PubMed ID: 27080930
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the global statistical test and composite outcome for secondary analyses of multiple coronary heart disease outcomes.
Baraniuk S; Seay R; Sinha AK; Piller LB
Prog Cardiovasc Dis; 2012; 54(4):357-61. PubMed ID: 22226004
[TBL] [Abstract][Full Text] [Related]
15. A joint model for longitudinal continuous and time-to-event outcomes with direct marginal interpretation.
Efendi A; Molenberghs G; Njagi EN; Dendale P
Biom J; 2013 Jul; 55(4):572-88. PubMed ID: 23606452
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study.
Claggett B; Tian L; Fu H; Solomon SD; Wei LJ
Stat Med; 2018 Nov; 37(25):3589-3598. PubMed ID: 30047148
[TBL] [Abstract][Full Text] [Related]
17. On recurrent-event win ratio.
Mao L; Kim K; Li Y
Stat Methods Med Res; 2022 Jun; 31(6):1120-1134. PubMed ID: 35345957
[TBL] [Abstract][Full Text] [Related]
18. An alternative approach to confidence interval estimation for the win ratio statistic.
Luo X; Tian H; Mohanty S; Tsai WY
Biometrics; 2015 Mar; 71(1):139-145. PubMed ID: 25156540
[TBL] [Abstract][Full Text] [Related]
19. A systematic comparison of recurrent event models for application to composite endpoints.
Ozga AK; Kieser M; Rauch G
BMC Med Res Methodol; 2018 Jan; 18(1):2. PubMed ID: 29301487
[TBL] [Abstract][Full Text] [Related]
20. Use of win time for ordered composite endpoints in clinical trials.
Troendle JF; Leifer ES; Yang S; Jeffries N; Kim DY; Joo J; O'Connor CM
Stat Med; 2024 May; 43(10):1920-1932. PubMed ID: 38417455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
